Literature DB >> 8616756

The changes of the stromal elastotic framework in the growth of peripheral lung adenocarcinomas.

T Eto1, H Suzuki, A Honda, Y Nagashima.   

Abstract

BACKGROUND: Most peripheral lung adenocarcinomas form a characteristic central fibrosis; however, the mechanism of formation has not yet been clarified.
METHODS: The stromal elastosis of 176 patients with peripheral lung adenocarcinomas was studied histologically, morphometrically, radiographically, and clinicopathologically.
RESULTS: The tumors were classified into two types, according to the histomorphological pattern of the stromal elastosis: (1) a preserved framework composed of a uniformly thick stroma (Type 1; 20 patients) and (2) a disrupted framework in the central fibrosis in which many air spaces were collagenized or collapsed (Type 2; 156 patients). Around the central fibrosis in the Type 2 tumors, replacement growth took the form of a thin-walled, elastic framework. Image analysis disclosed that the elastotic framework had an increased elastic fiber volume (approximately three- to nine-fold, compared with the normal alveolar wall), especially in Type 1 tumors, related to the contraction of the pre-existing alveolar wall. In Type 2 replacement growth, the amount of elastic fibers was slightly increased, which suggested mild reaction of the pre-existing alveolar wall. Radiographically, Type 1 tumors were characterized by a gradual increase of the density without enlargement, while the Type 2 tumors often enlarged within a short period. Recurrence was seen in 54% of the patients with Type 2 tumors, but in none of those with Type 1 tumors.
CONCLUSIONS: In the early development of peripheral adenocarcinoma, there is preservation of the elastotic framework (Type 1) of the stroma due to contraction and thickening of the alveolar walls. As the tumors grow, the elastotic framework is disrupted (Type 2), indicating stromal invasion. Based on the clinicopathologic findings and the outcome, Type 1 tumors may be in situ peripheral lung adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8616756

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  Multimodal non-linear optical imaging for label-free differentiation of lung cancerous lesions from normal and desmoplastic tissues.

Authors:  Xiaoyun Xu; Jie Cheng; Michael J Thrall; Zhengfan Liu; Xi Wang; Stephen T C Wong
Journal:  Biomed Opt Express       Date:  2013-11-15       Impact factor: 3.732

2.  Peripheral lung adenocarcinomas harboring epithelial growth factor receptor mutations with microRNA-135b overexpression are more likely to invade visceral pleura.

Authors:  Hanbo Le; Xiaoling Wang; Yao Zha; Jie Wang; Wangyu Zhu; Zhinan Ye; Xiaoguang Liu; Haijie Ma; Yongkui Zhang
Journal:  Oncol Lett       Date:  2017-10-16       Impact factor: 2.967

3.  A three-dimensional analysis of blood vessels in bronchioloalveolar carcinoma.

Authors:  Takeshi Uehara; Takayuki Honda; Kenji Sano; Tsutomu Hachiya; Hiroyoshi Ota
Journal:  Lung       Date:  2004       Impact factor: 2.584

4.  Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma.

Authors:  M Wislez; J Fleury-Feith; N Rabbe; J Moreau; D Cesari; B Milleron; C Mayaud; M Antoine; P Soler; J Cadranel
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

5.  The lysyl oxidase pro-peptide attenuates fibronectin-mediated activation of focal adhesion kinase and p130Cas in breast cancer cells.

Authors:  Yingshe Zhao; Chengyin Min; Siddharth R Vora; Philip C Trackman; Gail E Sonenshein; Kathrin H Kirsch
Journal:  J Biol Chem       Date:  2008-11-21       Impact factor: 5.157

Review 6.  Small peripheral lung adenocarcinoma: CT and histopathologic characteristics and prognostic implications.

Authors:  Zhi-gang Chu; Zhi-gang Yang; Heng Shao; Zhi-yu Zhu; Wen Deng; Shi-si Tang; Jing Chen; Yuan Li
Journal:  Cancer Imaging       Date:  2011-12-28       Impact factor: 3.909

7.  Combining deep learning and coherent anti-Stokes Raman scattering imaging for automated differential diagnosis of lung cancer.

Authors:  Sheng Weng; Xiaoyun Xu; Jiasong Li; Stephen T C Wong
Journal:  J Biomed Opt       Date:  2017-10       Impact factor: 3.170

8.  CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF-β signaling.

Authors:  Tetsuro Taki; Yukihiro Shiraki; Atsushi Enomoto; Liang Weng; Chen Chen; Naoya Asai; Yoshiki Murakumo; Kohei Yokoi; Masahide Takahashi; Shinji Mii
Journal:  Cancer Sci       Date:  2020-10-24       Impact factor: 6.716

Review 9.  Elastin in pulmonary pathology: relevance in tumours with a lepidic or papillary appearance. A comprehensive understanding from a morphological viewpoint.

Authors:  Erik Thunnissen; Noriko Motoi; Yuko Minami; Daisuke Matsubara; Wim Timens; Yukio Nakatani; Yuichi Ishikawa; Ximena Baez-Navarro; Teodora Radonic; Hans Blaauwgeers; Alain C Borczuk; Masayuki Noguchi
Journal:  Histopathology       Date:  2021-09-23       Impact factor: 7.778

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.